Menthyl Salicylate
CAS 89-46-3
Menthyl Salicylate (CAS 89-46-3) is a pharmaceutical compound with 0 bioactivity targets and 15 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Urticaria thermal | 11 | 65.106 | 10061399 |
| Administration site erythema | 10 | 51.397 | 10074796 |
| Hypercholesterolaemia | 21 | 48.754 | 10020603 |
| Nail bed tenderness | 8 | 44.937 | 10049268 |
| Pigmentation disorder | 11 | 33.66 | 10062080 |
| Type 2 diabetes mellitus | 22 | 31.582 | 10067585 |
| Autonomic neuropathy | 8 | 31.322 | 10061666 |
| Vitamin B12 deficiency | 11 | 31.289 | 10047609 |
| Fibromyalgia | 22 | 30.569 | 10048439 |
| Scratch | 11 | 30.405 | 10039737 |
| Vulvovaginal swelling | 6 | 30.241 | 10071211 |
| Skin plaque | 11 | 27.929 | 10067723 |
| Dizziness postural | 11 | 27.369 | 10013578 |
| Secretion discharge | 12 | 27.341 | 10053459 |
| Osteoarthritis | 23 | 26.866 | 10031161 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| MENTHYL SALICYLATE, (+/-)- | 1368207 | SU | MTHSPL |
| menthyl salicylate | 1368207 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Menthyl Salicylate used for in pharmaceutical contexts?
Menthyl Salicylate (CAS 89-46-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Menthyl Salicylate?
Menthyl Salicylate has 15 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Urticaria thermal, Administration site erythema, Hypercholesterolaemia, Nail bed tenderness, Pigmentation disorder. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Menthyl Salicylate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Menthyl Salicylate with EU status "restricted".
What clinical phase is Menthyl Salicylate in?
No phase 1-4 clinical development badge is rendered for Menthyl Salicylate because the matched compound identifier rows do not contain a max-phase value.